Health Condition 1: L00-L08- Infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Habbe Kibreet Sagheer: 250 mg tablet, twice daily with water for 4 weeks
Control Intervention1: not applicable: not applicable
Sponsors
Central Council for Research in Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1. QÅ«bÄ? (Dermatophytosis) of 2. Patients with KOH positive 3. lesions having any of the following symptoms: Presence of pruritus and burning, Presence of scales, Presence of central clearing, Erythematous papules.
Exclusion criteria
Exclusion criteria: 1.Co-morbid conditions of the participants 2.Pregnant or Lactating Women 3.Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction 4.Known cases of Immuno-compromised states (HIV/ AIDS, etc.) Malignancies • Participants not willing to attend treatment schedule regularly 5.History of hypersensitivity to clotrimazole 6.Participants using the following medications: 7.Systemic antifungal within 15 days of baseline visit. 8.Systemic corticosteroids within 15 days of baseline visit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the safety of Unani Pharmacopoeial formulation Habbe-kibreet Sagheer in cases of QÅ«bÄ? (Dermatophytosis).Timepoint: 1st week , 4th week | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ To assess the efficacy of Unani Pharmacopoeial formulation Habbe-kibreet Sagheer in cases of QÅ«bÄ? (Dermatophytosis).Timepoint: 1st, 2nd, 3rd, 4th week | — |
Countries
India
Contacts
Public ContactDr Ahmed Minhajuddin
National Research Institute of Unani Medicine for Skin Disorders
Outcome results
None listed